Home/Filings/4/0000059478-21-000248
4//SEC Filing

Van Naarden Jacob 4

Accession 0000059478-21-000248

CIK 0000059478other

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 4:09 PM ET

Size

5.5 KB

Accession

0000059478-21-000248

Insider Transaction Report

Form 4
Period: 2021-12-28
Van Naarden Jacob
EVP & Pres., Lilly Oncology
Transactions
  • Award

    Restricted Stock Unit

    2021-12-28+3,6183,618 total
    Common Stock (3,618 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
  • [F2]The restricted stock units vest on February 1, 2024.

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1
  • filerCIK 0001661254

Filing Metadata

Form type
4
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:09 PM ET
Size
5.5 KB